- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Lumera Corporation (NASDAQ:LMRA), a leader in the field of photonic communications, announced today that Dr. Raluca Dinu, Vice President - Electro-Optic Business Unit, will speak at the Global Crown Capital Nanotechnology conference on November 7 in Palo Alto, CA. She is also scheduled to speak at the 30th Annual Paulson Investment Westergaard conference in New York on November 13. In both cases, Dinu will give an overview of Lumera Corporation's electro-optic capabilities and products.
Plexera Bioscience LLC, a wholly owned subsidiary of Lumera, announced that Dr. Joe Vallner, Chairman and CEO of Plexera, will be a speaker at the Acumen Biofin Rodman & Renshaw 9th Annual Healthcare conference in New York on November 5. Plexera also announced that Dr. Timothy Londergan, President and COO, will give an overview of Plexera at the 30th Annual Westergaard conference in New York on November 13.
Additional information on the Global Crown conference can be obtained at http://www.globalcrowncapital.com/ ; on the Acumen Biofin conference at http://www.rodmanandrenshaw.com/conferences?id=6 ; and on the Westergaard conference at http://guest.cvent.com/EVENTS/Info/Summary.aspx?e=a0ddf4ee-9c19-4885-beb7-63f886c15d33 .
About Lumera Corporation
Lumera is a leader in the field of photonic communications. The company designs electro-optic components based on proprietary polymer compounds for the communications/computing industries.
About Plexera Bioscience LLC
Plexera Bioscience LLC was established in July of 2007 as a wholly owned subsidiary of Lumera Corporation (NASDAQ:LMRA) and is focused on providing the life sciences market with tools, content, and methods to simplify and accelerate proteomic discovery for therapeutic antibodies as well as predictive biomarkers.
Certain statements contained in this release are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company's forward-looking statements include the following: market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and to develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products; and other risk factors identified from time to time in the company's SEC reports, including its Annual Report on Form 10-K, and its Quarterly Reports on Form 10-Q.
For more information, please click here
Hélène F. Jaillet, Ph.D, 425-398-6546
The Summit Group Communications
Todd Wolfenbarger, 801-595-1155
Copyright © Business Wire 2007If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Deep Space Industries and SFL selected to provide satellites for HawkEye 360’s Pathfinder mission: The privately-funded space-based global wireless signal monitoring system will be developed by Deep Space Industries and UTIAS Space Flight Laboratory May 26th, 2016
The next generation of carbon monoxide nanosensors May 26th, 2016
Gigantic ultrafast spin currents: Scientists from TU Wien (Vienna) are proposing a new method for creating extremely strong spin currents. They are essential for spintronics, a technology that could replace today's electronics May 25th, 2016
Novel gene therapy shows potential for lung repair in asthma May 18th, 2016
Nanometrics Announces Upcoming Investor Events May 10th, 2016